Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Bing‐Lin Wang"'
Publikováno v:
Frontiers in Physics, Vol 11 (2023)
With the increasing repetition rate of ultra-intense laser pulses, ion beams accelerated by these lasers show great potential for achieving high-repetition-rate, high-average-flux muon sources. Nonetheless, generating high-quality ion beams is a chal
Externí odkaz:
https://doaj.org/article/3c8680de468c4cc1bf12966fcea48f15
Autor:
Su‐Yan Wang, Yi‐Bo Pang, Yuan Tao, Xin‐Chi Shi, Yun‐Jiao Zhang, Yan‐Xia Wang, Yong‐Hui Jiang, Xin‐Yu Ji, Bing‐Lin Wang, Daniela D. Herrera‐Balandrano, Pedro Laborda
Publikováno v:
Pest Management Science.
Autor:
Sheng-Yong Yang, Yu-Quan Wei, Shuang Zhang, Xin Chen, Zerong Wang, Pan Ji, Xiaoyan Wang, Zhixing Cao, Jingjing Liu, Yang Yu, Bing-Lin Wang, Han-Yu Yang, Lei Zhong, Lijiao Wang, Jiao Yang, Renlin Zheng, Shidong Luo, Shan Feng, Yong Xu, Youli Pan
PDF file - 466K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eb99f97bd9dee1104244117619da065
https://doi.org/10.1158/1535-7163.22497558
https://doi.org/10.1158/1535-7163.22497558
Autor:
Sheng-Yong Yang, Yu-Quan Wei, Shuang Zhang, Xin Chen, Zerong Wang, Pan Ji, Xiaoyan Wang, Zhixing Cao, Jingjing Liu, Yang Yu, Bing-Lin Wang, Han-Yu Yang, Lei Zhong, Lijiao Wang, Jiao Yang, Renlin Zheng, Shidong Luo, Shan Feng, Yong Xu, Youli Pan
Anti-epidermal growth factor receptor (EGFR) treatment has been successfully applied in clinical cancer therapy. However, the clinical efficacy of first-generation reversible EGFR inhibitors, such as gefitinib and erlotinib, is limited by the develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2621e52574010df5c8cf02d5a2226698
https://doi.org/10.1158/1535-7163.c.6535656.v1
https://doi.org/10.1158/1535-7163.c.6535656.v1
Publikováno v:
Pharmacology & Therapeutics. 219:107694
Programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) blockade has been approved as the standard-of-care for the treatment of non-small cell lung cancer (NSCLC). Yet, the population of patients who benefit from the treatment remains modest
Autor:
Bing-lin Wang, Bing Zhu, Guanglei Tian, Hao Ren, Xiaohu Ge, Li-mu Sai, Feng Zhu, Xiao-kui Jiang, Qingbo Fang, Sheng Guan, Chang-min Wang, Hongbo Ci
Publikováno v:
Blood Coagulation & Fibrinolysis. 25:114-118
To assess the association between polymorphisms of prothrombin gene and hereditary thrombophilia in Xinjiang Kazakhs population. Through cross-sectional investigation, permanent Kazakh population of Ili Kazakh Autonomous Prefecture was selected as th
Publikováno v:
Journal of Fluorine Chemistry. 136:12-19
Salinosporamide A is an irreversible inhibitor of the beta-subunits of the 20S proteasome. Its C-5 cyclohexenyl moiety is the key to its affinity and potency as an anticancer agent. Here we describe the synthesis of C-5 difluoromethylated and trifluo
Publikováno v:
Tetrahedron. 63:12671-12680
Trifluoromethylated analogs of macrosphelide A 1 and 2 were designed and synthesized. The key segment 6 was efficiently constructed via a series of high stereoselective transformations from trifluoromethylated diol 8 . Methoxymethylation of compound
Publikováno v:
ChemInform. 43
Salinosporamide A is an irreversible inhibitor of the beta-subunits of the 20S proteasome. Its C-5 cyclohexenyl moiety is the key to its affinity and potency as an anticancer agent. Here we describe the synthesis of C-5 difluoromethylated and trifluo
Publikováno v:
ChemInform. 37
Efficient strategy to trifluoromethylated trans -disubstituted alkene 3 was developed starting from commercially available 4,4,4-trifluoro-3-oxo-butyric acid ethyl ester 12 . 6-Deoxy-6,6,6-trifluorosugars 21 and 30 were synthesized from 3 in high ste